Chowdhury Ananda, Marin Alexander, Weber David J, Andrianov Alexander K
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA.
Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene St., Baltimore, MD 21201, USA.
Pharmaceutics. 2021 Nov 2;13(11):1834. doi: 10.3390/pharmaceutics13111834.
Self-assembly of ionically charged small molecule drugs with water-soluble biodegradable polyelectrolytes into nano-scale complexes can potentially offer a novel and attractive approach to improving drug solubility and prolonging its half-life. Nanoassemblies of quisinostat with water-soluble PEGylated anionic polyphosphazene were prepared by gradient-driven escape of solvent resulting in the reduction of solvent quality for a small molecule drug. A study of binding, analysis of composition, stability, and release profiles was conducted using asymmetric flow field flow fractionation (AF4) and dynamic light scattering (DLS) spectroscopy. Potency assays were performed with WM115 human melanoma and A549 human lung cancer cell lines. The resulting nano-complexes contained up to 100 drug molecules per macromolecular chain and displayed excellent water-solubility and improved hemocompatibility when compared to co-solvent-based drug formulations. Quisinostat release time (complex dissociation) at near physiological conditions in vitro varied from 5 to 14 days depending on initial drug loading. Multimeric complexes displayed dose-dependent potency in cell-based assays and the results were analyzed as a function of complex concentration, as well as total content of drug in the system. The proposed self-assembly process may present a simple alternative to more sophisticated delivery modalities, namely chemically conjugated prodrug systems and nanoencapsulation-based formulations.
将带离子电荷的小分子药物与水溶性可生物降解聚电解质自组装成纳米级复合物,可能为提高药物溶解度和延长其半衰期提供一种新颖且有吸引力的方法。通过溶剂的梯度驱动逸出制备喹西他滨与水溶性聚乙二醇化阴离子聚磷腈的纳米组装体,这导致小分子药物的溶剂质量降低。使用不对称流场流分馏(AF4)和动态光散射(DLS)光谱对结合、组成分析、稳定性和释放曲线进行了研究。对WM115人黑色素瘤和A549人肺癌细胞系进行了效价测定。与基于共溶剂的药物制剂相比,所得纳米复合物每条大分子链最多包含100个药物分子,并表现出优异的水溶性和改善的血液相容性。在体外接近生理条件下,喹西他滨的释放时间(复合物解离)根据初始药物负载量在5至14天之间变化。多聚体复合物在基于细胞的测定中显示出剂量依赖性效价,并且将结果作为复合物浓度以及系统中药物总含量的函数进行分析。所提出的自组装过程可能是更复杂递送方式(即化学共轭前药系统和基于纳米封装的制剂)的一种简单替代方法。